Related Experiment Video
Updated: Aug 10, 2026
Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia
Published on: August 28, 2013
[Xenograft]
1Nefrologisk afdeling, Odense Universitetshospital.
Abstract:
The ultimate purpose of research in xenografting (cross-species transplantation) is successful transplantation of tissue and organs from animals to human patients. Success in the clinical application of xenografting would mean an end to the shortage of donor organs. Xenografts are classified as concordant or discordant, depending on rejection factors and histology. Several clinical attempts have been made since 1963, but success has been limited. However, great progress has been made in laboratory attempts; and the procedures should now be given clinical trials. This success has been due to the efficacy of many of the newly developed immunosuppressive drugs. Discordant xenografting is still problematic, and in this type of transplantation the most promising approach would seem to be with isolated cells or cell clusters.
Insights
Xenografting research aims to transplant animal organs into humans, potentially solving donor shortages. Advances in immunosuppressive drugs and lab success suggest clinical trials for xenotransplantation are now feasible.
Area of Science:
- Transplantation immunology
- Regenerative medicine
- Surgical innovation
Context:
- Addressing the critical shortage of human donor organs for transplantation.
- Reviewing the history and classification (concordant vs. discordant) of xenografts.
- Evaluating past clinical attempts and recent laboratory advancements in cross-species transplantation.
Purpose:
- To explore the potential of xenografting as a solution to organ scarcity.
- To assess the progress in xenotransplantation techniques and their clinical applicability.
- To identify promising strategies for overcoming rejection barriers in xenografting.
Summary:
- Xenografting, or cross-species transplantation, holds the promise of alleviating organ donor shortages.
- Recent laboratory successes, driven by novel immunosuppressive drugs, indicate readiness for clinical trials.
- While concordant xenografts show promise, discordant xenografting remains challenging, with isolated cells being a potential solution.
Impact:
- Potential to eliminate waiting lists for organ transplantation.
- Advancement of immunosuppressive therapies and transplantation protocols.
- Opening new avenues for regenerative medicine through cross-species cell and tissue therapies.
